DE69131398D1 - Verwendung von 5-ht4 rezeptorantagonisten zur behandlung von vorhof-fibrillation und zur vorbeugung von schlaganfall - Google Patents

Verwendung von 5-ht4 rezeptorantagonisten zur behandlung von vorhof-fibrillation und zur vorbeugung von schlaganfall

Info

Publication number
DE69131398D1
DE69131398D1 DE69131398T DE69131398T DE69131398D1 DE 69131398 D1 DE69131398 D1 DE 69131398D1 DE 69131398 T DE69131398 T DE 69131398T DE 69131398 T DE69131398 T DE 69131398T DE 69131398 D1 DE69131398 D1 DE 69131398D1
Authority
DE
Germany
Prior art keywords
receptor antagonists
atrial fibrillation
treating atrial
preventing stroke
stroke
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69131398T
Other languages
English (en)
Other versions
DE69131398T2 (de
Inventor
Alberto Julio Kaumann
Francis David King
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Beecham Group PLC
Smith Kline and French Laboratories Ltd
GlaxoSmithKline LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC, Smith Kline and French Laboratories Ltd, GlaxoSmithKline LLC filed Critical Beecham Group PLC
Publication of DE69131398D1 publication Critical patent/DE69131398D1/de
Application granted granted Critical
Publication of DE69131398T2 publication Critical patent/DE69131398T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Polarising Elements (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
DE69131398T 1990-04-26 1991-04-24 Verwendung von 5-ht4 rezeptorantagonisten zur behandlung von vorhof-fibrillation und zur vorbeugung von schlaganfall Expired - Fee Related DE69131398T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909009389A GB9009389D0 (en) 1990-04-26 1990-04-26 Treatment
PCT/GB1991/000650 WO1991016045A2 (en) 1990-04-26 1991-04-24 Use of 5-ht4 receptor antagonists in the treatment of arrythmias and stroke

Publications (2)

Publication Number Publication Date
DE69131398D1 true DE69131398D1 (de) 1999-08-05
DE69131398T2 DE69131398T2 (de) 2000-03-02

Family

ID=10675031

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69131398T Expired - Fee Related DE69131398T2 (de) 1990-04-26 1991-04-24 Verwendung von 5-ht4 rezeptorantagonisten zur behandlung von vorhof-fibrillation und zur vorbeugung von schlaganfall

Country Status (14)

Country Link
EP (1) EP0526540B1 (de)
JP (2) JPH05509293A (de)
AT (1) ATE181668T1 (de)
AU (1) AU653521B2 (de)
CA (1) CA2081344C (de)
DE (1) DE69131398T2 (de)
DK (1) DK0526540T3 (de)
ES (1) ES2134774T3 (de)
GB (1) GB9009389D0 (de)
GR (1) GR3031042T3 (de)
IE (1) IE911383A1 (de)
PT (1) PT97477B (de)
WO (1) WO1991016045A2 (de)
ZA (1) ZA913071B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020128172A1 (en) 1991-12-21 2002-09-12 Smithkline Beecham Plc Use of 5-HT4 modulators for the manufacture of a medicament for the treatment of the bladder diseases
US5852014A (en) * 1992-03-12 1998-12-22 Smithkline Beecham P.L.C. Condensed indole derivatives as 5HT4 -receptor antagonists
US5998409A (en) * 1992-03-12 1999-12-07 Smithkline Beecham Plc Condensed indole derivatives as 5HT4 -receptor antagonists
EP0664794A1 (de) * 1992-10-16 1995-08-02 Smithkline Beecham Plc N-alkylpiperidinyl-4-methyl-carbonsäure ester/amide von kondensierten ring-systemen als 5-ht4-rezeptor antagonisten
GB9301660D0 (en) * 1993-01-28 1993-03-17 Smithkline Beecham Plc Pharmaceuticals
US5684003A (en) * 1994-10-20 1997-11-04 Nisshin Flour Milling Co., Ltd. 5-HT4 receptor agonists
PL365048A1 (en) * 2000-08-07 2004-12-27 Laboratoire Glaxosmithkline S.A.S. Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
GB0211230D0 (en) * 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
US7737163B2 (en) 2004-06-15 2010-06-15 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
AU2005254800B2 (en) 2004-06-15 2010-12-09 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
EP2153830A1 (de) * 2008-08-07 2010-02-17 Sanofi-Aventis Verwendung von Dronedaron zur Herstellung eines Medikaments zur Prävention von Schlaganfällen oder transienten ischämischen Anfällen
PL3176164T3 (pl) 2014-07-30 2020-05-18 Aetas Pharma Co. Ltd. Izomer optyczny pochodnej 1-tlenku 1,4-benzotiazepiny oraz farmaceutyczna kompozycja wytworzona z jego użyciem

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3687080T2 (de) * 1985-04-27 1993-03-25 Beecham Group Plc Azabicyclononyl-indazol-carboxamid mit 5-ht-antagonistischer wirkung.
US4731643A (en) * 1985-10-21 1988-03-15 International Business Machines Corporation Logic-circuit layout for large-scale integrated circuits

Also Published As

Publication number Publication date
CA2081344A1 (en) 1991-10-27
PT97477B (pt) 1998-08-31
ZA913071B (en) 1992-11-25
WO1991016045A2 (en) 1991-10-31
PT97477A (pt) 1992-01-31
ATE181668T1 (de) 1999-07-15
EP0526540A1 (de) 1993-02-10
JP2003267890A (ja) 2003-09-25
IE911383A1 (en) 1991-11-06
AU653521B2 (en) 1994-10-06
EP0526540B1 (de) 1999-06-30
WO1991016045A3 (en) 1991-12-26
AU7768091A (en) 1991-11-11
CA2081344C (en) 2003-10-21
GB9009389D0 (en) 1990-06-20
GR3031042T3 (en) 1999-12-31
JPH05509293A (ja) 1993-12-22
DE69131398T2 (de) 2000-03-02
DK0526540T3 (da) 1999-11-22
ES2134774T3 (es) 1999-10-16

Similar Documents

Publication Publication Date Title
DE68928051T2 (de) Behandlung von humanem Kollagen und Verwendung als Auto-Implantat
DE69022249T2 (de) Knochenwachsapplikator zur Behandlung von Knochengewebe.
DE693928T1 (de) Aminozucker- und glykosaminoglykanzusammensetzung zur behandlung und reparatus von bindegewebe
NO924619D0 (no) (+)-alfa-(2,3-dimetoksyfenyl)-1-(2-(4-fluorfenyl)ethyl)-4-piperidinmetanol
DE69528475T2 (de) Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie
DE69130437D1 (de) Gerät mit neuronalen Netzwerken zur Detektion und Behandlung von Arrythmien
IT1232889B (it) Composizioni e procedimento per il trattamento ammorbidente di tessuti
ATE218854T1 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin- abhängigen protein kinase
DE69212620T2 (de) Verwendung von Glycosaminoglycanen zur Behandlung von diabetischer Nephropathie und diabetischer Neuropathie
DE69131398T2 (de) Verwendung von 5-ht4 rezeptorantagonisten zur behandlung von vorhof-fibrillation und zur vorbeugung von schlaganfall
ATE106736T1 (de) Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes.
DE69133390D1 (de) Verwendung von angiotensin-ii-rezeptorantagonisten in der behandlung von hämorragischem schlaganfall
PT888114E (pt) Utilizacao de (+)-alfa-(2,3-dimetoxifenil)-1-¬2-(4-fluorofenil)etil|-4-piperidinometanol no tratamento de doencas depressivas e doencas bipolares
DE3856329D1 (de) Verwendung von Ethisterone zur topischen Behandlung von Akne oder androgenetischer Alopezie
DE58902451D1 (de) (s)-emopamil zur anwendung bei der behandlung von migraene.
DE69132782D1 (de) Verwendung von angiotensin-ii-antagonisten in der behandlung der linken ventrikulären hypertrophie
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
DE69004924D1 (de) Therapeutische verwendung von 5-ht3-rezeptor-antagonisten.
DE59410340D1 (de) Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen
ATE96039T1 (de) Arzneimittel und ihre verwendung zur behandlung von parasitosen.
DE69117566D1 (de) Verwendung von Isomonoolen zur Behandlung und Prophylaxe von Krebserkrankungen
ATE88090T1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
ATE274328T1 (de) Behandlung und fixierung von gewebe
ATE73167T1 (de) Verfahren bei der behandlung von aluminium und verwendung bestimmter saeuren in den dabei benutzten oelen.
DE68906028T2 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: SMITH KLINE & FRENCH LABORATORIES LTD., BRENTFORD,

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee